{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:11:29Z","timestamp":1780449089435,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006389","name":"University of Geneva","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008644","name":"McGill University Faculty of Medicine and Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008644","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019688","name":"Department of Medicine, Georgetown University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.atherosclerosis.2022.02.023","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T19:44:17Z","timestamp":1646423057000},"page":"41-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Outcomes with revascularization and medical therapy in patients with coronary disease and chronic kidney disease: A meta-analysis"],"prefix":"10.1016","volume":"351","author":[{"given":"Alexandre","family":"Leszek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauriane","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Zbinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6171-1269","authenticated-orcid":false,"given":"Lucas C.","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7528-7363","authenticated-orcid":false,"given":"Jean-Luc","family":"Reny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Charytan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3368-247X","authenticated-orcid":false,"given":"Thomas A.","family":"Mavrakanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ki.2010.536","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts","volume":"79","author":"van der Velde","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib3","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2215\/CJN.00150106","article-title":"Kidney function and use of recommended medications after myocardial infarction in elderly patients","volume":"1","author":"Winkelmayer","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.ajkd.2019.04.018","article-title":"Comparative effectiveness of medical therapy, percutaneous revascularization, and surgical coronary revascularization in cardiovascular risk subgroups of patients with CKD: a retrospective cohort study of Medicare beneficiaries","volume":"74","author":"Charytan","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.kint.2016.09.049","article-title":"Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review","volume":"91","author":"Mathew","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib6","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/sj.ki.5001934","article-title":"The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease","volume":"70","author":"Charytan","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib7","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1681\/ASN.2018070674","article-title":"Persistent underrepresentation of kidney disease in randomized, controlled trials of cardiovascular disease in the contemporary era","volume":"29","author":"Maini","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib8","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.amjmed.2016.06.046","article-title":"Optimal treatment strategies in patients with chronic kidney disease and coronary artery disease","volume":"129","author":"Volodarskiy","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153478","article-title":"Impact of an early invasive strategy versus conservative strategy for unstable angina and non-ST elevation acute coronary syndrome in patients with chronic kidney disease: a systematic review","volume":"11","author":"Shaw","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Contr. Clin. Trials"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib11","author":"Wells"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jacc.2018.11.044","article-title":"Impact of chronic kidney disease on outcomes of myocardial revascularization in patients with diabetes","volume":"73","author":"Farkouh","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib14","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2215\/CJN.05551008","article-title":"Early angiography in patients with chronic kidney disease: a collaborative systematic review","volume":"4","author":"Charytan","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib15","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0140-6736(92)93010-K","article-title":"Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure","volume":"340","author":"Manske","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1056\/NEJMoa1915925","article-title":"Management of coronary disease in patients with advanced kidney disease","volume":"382","author":"Bangalore","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib17","first-page":"453","article-title":"Renal dysfunction, coronary revascularization and mortality among elderly patients with non ST elevation acute coronary syndrome","volume":"4","author":"Morici","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib18","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/01.CIR.0000143629.55725.D9","article-title":"Survival after coronary revascularization among patients with kidney disease","volume":"110","author":"Hemmelgarn","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib19","first-page":"764","article-title":"Relationship of chronic kidney disease to cardiovascular death and myocardial infarction following coronary stenting","volume":"19","author":"Charytan","year":"2006","journal-title":"J. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib20","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2005.11.028","article-title":"Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction?","volume":"97","author":"Dragu","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcin.2008.09.010","article-title":"Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events)","volume":"2","author":"Medi","year":"2009","journal-title":"JACC Cardiovasc. Interv."},{"issue":"Suppl","key":"10.1016\/j.atherosclerosis.2022.02.023_bib22","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3346\/jkms.2009.24.S1.S87","article-title":"The association between kidney function, coronary artery disease, and clinical outcome in patients undergoing coronary angiography","volume":"24","author":"Na","year":"2009","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.108.838169","volume":"120","author":"Szummer","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib24","first-page":"1451","article-title":"Invasive strategy in non-ST elevation acute coronary syndromes: risks and benefits in an elderly population","volume":"29","author":"Louren\u00e7o","year":"2010","journal-title":"Rev. Port. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.amjcard.2011.03.025","article-title":"Management of non-ST-segment elevation acute myocardial infarction in patients with chronic kidney disease (from the Korea Acute Myocardial Infarction Registry)","volume":"108","author":"Hachinohe","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000332588","article-title":"Timing of coronary angiography and outcome in patients with non-ST elevation acute coronary syndromes and kidney disease: real-world data from the acute coronary syndromes Israeli survey","volume":"119","author":"Young Altahan","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib27","doi-asserted-by":"crossref","first-page":"f4151","DOI":"10.1136\/bmj.f4151","article-title":"Renal outcomes associated with invasive versus conservative management of acute coronary syndrome: propensity matched cohort study","volume":"347","author":"James","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2369-15-66","article-title":"Impact of impaired glomerular filtration rate and revascularization strategy on one-year cardiovascular events in acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registry","volume":"15","author":"Lin","year":"2014","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099925","article-title":"Inpatient coronary angiography and revascularisation following non-ST-elevation acute coronary syndrome in patients with renal impairment: a cohort study using the Myocardial Ischaemia National Audit Project","volume":"9","author":"Shaw","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib30","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.athoracsur.2015.10.036","article-title":"Impact of chronic kidney disease on long-term outcomes in type 2 diabetic patients with coronary artery disease on surgical, angioplasty, or medical treatment","volume":"101","author":"Lima","year":"2016","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5603\/KP.a2017.0013","article-title":"Renal function on admission affects both treatment strategy and long-term outcomes of patients with myocardial infarction (from the Polish Registry of Acute Coronary Syndromes)","volume":"75","author":"Hawranek","year":"2017","journal-title":"Kardiol. Pol."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2016.11.026","article-title":"Management and outcomes of acute myocardial infarction in patients with chronic kidney disease","volume":"227","author":"Smilowitz","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MCA.0000000000000557","article-title":"Long-term patient and kidney survival after coronary artery bypass grafting, percutaneous coronary intervention, or medical therapy for patients with chronic kidney disease: a propensity-matched cohort study","volume":"29","author":"Vuurmans","year":"2018","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007920","article-title":"Non-ST-segment-elevation myocardial infarction among patients with chronic kidney disease: a propensity score-matched comparison of percutaneous coronary intervention versus conservative management","volume":"7","author":"Bhatia","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/ehjqcco\/qcx042","article-title":"Kidney function modifies the selection of treatment strategies and long-term survival in stable ischaemic heart disease: insights from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry","volume":"4","author":"Shavadia","year":"2018","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib36","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1253\/circj.CJ-17-1272","article-title":"Revascularization vs. medical therapy for coronary chronic total occlusions in patients with chronic kidney disease","volume":"82","author":"Kim","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib37","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/qjmed\/hcz130","article-title":"Cardiovascular and renal outcomes following percutaneous coronary intervention in a population with renal disease: a case-control study","volume":"112","author":"Allen","year":"2019","journal-title":"QJM"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib38","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib39","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib40","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.CIR.89.4.1545","article-title":"Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia","volume":"89","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib41","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","article-title":"Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib42","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib43","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/euhj.2001.2735","article-title":"Value of first day angiography\/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study","volume":"23","author":"Spacek","year":"2002","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib44","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa044259","article-title":"Early invasive versus selectively invasive management for acute coronary syndromes","volume":"353","author":"de Winter","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib45","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.006363","article-title":"Effect of percutaneous coronary intervention on death and myocardial infarction stratified by stable and unstable coronary artery disease: a meta-analysis of randomized controlled trials","volume":"13","author":"Chacko","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib47","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.120.048194","article-title":"Routine revascularization versus initial medical therapy for stable ischemic heart disease: a systematic review and meta-analysis of randomized trials","volume":"142","author":"Bangalore","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib48","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jacc.2019.07.062","article-title":"From detecting the vulnerable plaque to managing the vulnerable patient","volume":"74","author":"Arbab-Zadeh","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3 Suppl","key":"10.1016\/j.atherosclerosis.2022.02.023_bib49","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.jcmg.2011.12.008","article-title":"Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes","volume":"5","author":"Baber","year":"2012","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10157-012-0682-7","article-title":"Angiographic characteristics of coronary arterial segments progressing to myocardial infarction in patients with and without chronic kidney disease","volume":"17","author":"Charytan","year":"2013","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2022.02.023_bib51","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N. Engl. J. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502200106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502200106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:27:01Z","timestamp":1762187221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191502200106X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":51,"alternative-id":["S002191502200106X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.02.023","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes with revascularization and medical therapy in patients with coronary disease and chronic kidney disease: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}